METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First patients to test promising new pill for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis is the first study in people to test the safety of a new oral drug called (R)-9bMS for advanced prostate cancer that has spread and no longer responds to standard hormone therapies. The trial will enroll about 40 men to find the safest and most effective dose. The goal is to…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: TechnoGenesys, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Radioactive 'Trojan Horse' targets advanced prostate cancer in new trial
Disease control Recruiting nowThis study is testing an experimental treatment for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapies. The treatment uses a radioactive drug that specifically seeks out and attaches to prostate cancer cells to damage them from …
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Triple-Threat attack on advanced prostate cancer
Disease control Recruiting nowThis study is testing whether combining a bone-targeting radiation drug with one or two other medications works better for advanced prostate cancer that has spread to bones and stopped responding to standard hormone therapy. It will compare three approaches: the radiation drug al…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test Two-Drug punch for tough prostate cancer
Disease control Recruiting nowThis study is testing a two-step treatment for advanced prostate cancer that has spread and stopped responding to standard hormone therapies and chemotherapy. First, patients take a pill (abemaciclib) for two weeks, aiming to make cancer cells more visible. Then, they receive a t…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Vadim S Koshkin • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New scan aims to sharpen the picture of prostate cancer
Diagnosis Recruiting nowThis study is testing a new type of imaging scan to see if it can clearly show where prostate cancer has spread in the body. It will compare this new scan to another type of scan that is already used. The goal is to see if the new scan is a good tool for patients who are schedule…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC